Transcobalamin II Deficiency Can Present without Hematological Manifestations: A Novel TCN2 Gene Variant

Muhammad Matloob Alam *

Department of Hematology/Oncology, Armed Forces Hospital, Alhada, Taif, Saudi Arabia.

Abdulrhman Alathaibi

Department of Hematology/Oncology, Armed Forces Hospital, Alhada, Taif, Saudi Arabia.

Riffat Matloob

Aga Khan University Hospital (Alumni), Karachi, Pakistan.

Mohammed Ahmed Oshi

Division of Neurology, Department of Pediatric, Armed Forces Hospital, Alhada, Taif, Saudi Arabia.

*Author to whom correspondence should be addressed.


Abstract

Transcobalamin II (TC) deficiency is a rare but serious metabolic disorder. It usually presents in the first year of life with failure to thrive, megaloblastic anemia and pancytopenia. Other features includes hypotonia, ataxia, lethargy, vomiting, diarrhea, mucosal ulceration, recurrent infections, agammaglobulinemia, methylmalonic aciduria and in rare cases, seizures. Besides, clinical presentation of TC deficiency may not be obvious thus leading to complex issues around diagnosis and treatment. Herein, we present TC II deficiency diagnosed in a 14 months old boy who presented with progressive myoclonic seizure, ataxia, truncal hypotonia, without any hematological manifestations and found to have a novel variant in the TCN2 gene.

Keywords: Transcobalamin II deficiency, TCN2 gene, megaloblastic anemia, pancytopenia, neurological deficits


How to Cite

Alam, Muhammad Matloob, Abdulrhman Alathaibi, Riffat Matloob, and Mohammed Ahmed Oshi. 2022. “Transcobalamin II Deficiency Can Present Without Hematological Manifestations: A Novel TCN2 Gene Variant”. Asian Hematology Research Journal 5 (3):101-5. https://journalahrj.com/index.php/AHRJ/article/view/120.

Downloads

Download data is not yet available.